Educators located in the United States at an accredited educational institution can place a bulk order: Ancestry Service for $79 or Health + Ancestry Service for $99, plus standard shipping ($9.95 first kit, $5 each additional kit). Credit card or Paypal payment.
Order a 23andMe Health + Ancestry Service
or 23andMe Ancestry Service
Register your saliva collection tube
Spit in the tube provided
following the full instructions in the kit insert
Mail it back in the pre-paid package
Track the lab processing status online
Discover what your DNA
says about you!
– Our Genetic Health Risk** and Carrier Status** reports meet FDA criteria for being scientifically and clinically valid
– All saliva samples are processed in CLIA-certified and CAP-accredited labs
– Our DNA collection kit is FDA-cleared for use with our Genetic Health Risk and Carrier Status reports
– Our kit is manufactured in accordance with FDA’s Good Manufacturing Practice regulations
– Genotyping is a well-established and reliable platform for analyzing DNA
– Our team of scientists and medical experts uses a robust process to develop reports to ensure validity
– Ancestry percentages are derived from our powerful, well-tested system that provides you with ancestry estimates down to the 0.1%
Everyone deserves a secure, private place to explore and understand their genetics. At 23andMe, we put you in control of deciding what information you want to learn and what information you want to share.
We’re committed to complying with the EU’s new data protection law, referred to as the GDPR. Visit our GDPR page to learn about our data protection approach.
Please contact us at privacy@23andMe.com if you have questions.
*23andMe kit may NOT be redistributed or resold, must be used for educational purposes by educators and college students located in the United States at an accredited educational institution only, and is subject to 23andMe’s Terms of Service and Privacy Statement. Education discount may NOT be applied to a prior purchase of the 23andMe kit or combined with any other offer or discount. Offer is non-transferable and subject to change without notice. Credit card or Paypal payment. Limit one discounted kit per customer.
**The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child’s risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/
This feature is temporarily unavailable, but please check back later.